GRAIL, Inc.
NASDAQ:GRALMedical - Diagnostics & Research
+$1.90 today
- Market cap
- $4.59B
- Beta
- 3.16
- P/E (TTM)
- -6.3
- EPS (TTM)
- -$9.73
Volume 0.62M
Average 0.77M
GRAL Weighted Avg Shares (Diluted)
Average shares outstanding including dilutive securities, used to calculate diluted EPS.
GRAIL, Inc.NASDAQ: GRAL
Weighted Avg Shares (Diluted) · Q2 FY2026 · quarter ended Jun 2026
Weighted avg shares (diluted) growth accelerates
Q2 FY2026 weighted avg shares (diluted) of 43.11M shares rose 23.0% year over year, ahead of the +20.6% change in trailing-twelve-month weighted avg shares (diluted). Sequentially, it rose 6.1% from the prior quarter. Over 3 fiscal years it compounded at +5.8% a year.
Context
- Weighted avg shares (diluted) increased in 2 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly growth of +23.0% holds above the trailing-twelve-month pace of +20.6%.
Sources:Income StatementText generated from reported figures; not investment advice.
Weighted Avg Shares (Diluted) history
Shares · from the income statement
- Latest · FY2025
- 36.75M USD
- Year-over-year change
- +15.2%
- 4-year CAGR
- +4.3%
| Period | Period end | Weighted Avg Shares (Diluted) | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 36.75M | +15.2% |
| FY2024 | 2024-12-31 | 31.9M | +2.7% |
| FY2023 | 2023-12-31 | 31.05M | +0.0% |
| FY2022 | 2022-12-31 | 31.05M | +0.0% |
| FY2021 | 2021-12-31 | 31.05M | — |
Weighted Avg Shares (Diluted) vs competitors
How GRAL compares with its peers on the latest reported figures
- GRAL's LTM Jun 2026 weighted avg shares (diluted) of 40.15M shares is the 7th highest of the 10 companies compared; the peer median is 93.15M shares.
- Its year-over-year change of +20.6% is the 2nd highest of 10, against a peer median of +2.4%.
- Over three fiscal years its annual growth of +5.8% compares with a peer median of +6.0%.
| Company | Period | LTM | YoY | 3-year CAGR |
|---|---|---|---|---|
| LTM Jun 2026 | 139.67M | +7.5% | +11.6% | |
| LTM Sep 2026 | 131.61M | +5.9% | +7.1% | |
| LTM Jun 2026 | 129.14M | +1.5% | +1.0% | |
| LTM Mar 2026 | 93.42M | +36.5% | +25.0% | |
| LTM Mar 2026 | 93.15M | +2.4% | +5.0% | |
BLLNBillionToOne, Inc. | LTM Jun 2026 | 49.5M | +10.7% | — |
| LTM Jun 2026 | 40.15M | +20.6% | +5.8% | |
| LTM Mar 2026 | 30.81M | +1.0% | -0.2% | |
| LTM Mar 2026 | 29.46M | +0.8% | +3.6% | |
WGSGeneDx Holdings Corp. | LTM Jun 2026 | 28.68M | +2.4% | +38.0% |
| Peer median (excluding GRAL) | 93.15M | +2.4% | +6.0% | |
Competitors are the stored peer set for GRAL. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 14.61M | 55.55M | 93.11M | 125.6M | 147.17M |
| Cost of Revenue | 114.62M | 172M | 188.72M | 203.62M | 209.75M |
| Gross Profit | (100M) | (116.45M) | (95.61M) | (78.02M) | (62.57M) |
| Gross Margin | -684.4% | -209.6% | -102.7% | -62.1% | -42.5% |
| Research & Development | 460.21M | 329.58M | 338.75M | 322.38M | 195.79M |
| Selling, General & Admin | 234.06M | 296.44M | 362.56M | 367.82M | 275.8M |
| Operating Expenses | 1.17B | 5.33B | 1.42B | 2.11B | 471.59M |
| Depreciation & Amortization | 58.45M | 154.76M | 158.7M | 158.06M | 156.34M |
| EBITDA | (1.21B) | (587.7M) | (638.22M) | (610.17M) | (378.16M) |
| EBITDA Margin | -8259.0% | -1058.0% | -685.5% | -485.8% | -257.0% |
| Operating Income | (1.27B) | (5.44B) | (1.52B) | (2.19B) | (534.16M) |
| Operating Margin | -8659.6% | -9798.2% | -1627.6% | -1743.0% | -363.0% |
| Interest Income | 332K | 1.74M | 7.95M | 26.73M | 28.65M |
| Interest Expense | 0 | 0 | 0 | 0 | 0 |
| Other Income / Expenses | 90K | 1.5M | 7.75M | 26.8M | (341K) |
| Income Before Tax | (1.27B) | (5.44B) | (1.51B) | (2.16B) | (534.5M) |
| Pre-Tax Margin | -8659.0% | -9795.5% | -1619.3% | -1721.7% | -363.2% |
| Income Tax Expense | (17.48M) | (42.29M) | (41.95M) | (135.36M) | (126.15M) |
| Net Income | (1.25B) | (5.4B) | (1.47B) | (2.03B) | (408.35M) |
| Net Margin | -8539.4% | -9719.3% | -1574.2% | -1613.9% | -277.5% |
| EPS (Basic) | (40.18) | (173.87) | (47.20) | (63.54) | (11.11) |
| EPS (Diluted) | (40.18) | (173.87) | (47.20) | (63.54) | (11.11) |
| Weighted Avg Shares | 31.05M | 31.05M | 31.05M | 31.9M | 36.75M |
| Weighted Avg Shares (Diluted) | 31.05M | 31.05M | 31.05M | 31.9M | 36.75M |
GRAIL, Inc.
NASDAQ:GRAL
Intrinsic Alpha fair value
Locked
Current Price
$102.10
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.